Showing 1 - 10 of 34
This paper focuses on possible economic consequences of low fertility in Europe. It summarizes a selection of papers that were presented at a conference at the University of St. Gallen in April 2008. This introduction also reviews the history of falling fertility in Europe and the literature...
Persistent link: https://www.econbiz.de/10003931192
Persistent link: https://www.econbiz.de/10009424793
Persistent link: https://www.econbiz.de/10010516844
This paper provides estimates of the economic impact of non-communicable diseases (NCDs) in China and India for the period 2012-2030. Our estimates are derived using WHO's EPIC model of economic growth, which focuses on the negative effects of NCDs on labor supply and capital accumulation. We...
Persistent link: https://www.econbiz.de/10009792518
We use a new dataset on non-resource GDP to examine the performance of commodity-exporting countries in terms of macroeconomic stability and economic growth in a panel of up to 129 countries during the period 1970-2007. Our main findings are threefold. First, we find that overall government...
Persistent link: https://www.econbiz.de/10009388290
Persistent link: https://www.econbiz.de/10002369204
Persistent link: https://www.econbiz.de/10001640550
We use a new dataset on non-resource GDP to examine the performance of commodity-exporting countries in terms of macroeconomic stability and economic growth in a panel of up to 129 countries during the period 1970-2007. Our main findings are threefold. First, we find that overall government...
Persistent link: https://www.econbiz.de/10013117356
We use a new dataset on non-resource GDP to examine the performance of commodity-exporting countries in terms of macroeconomic stability and economic growth in a panel of up to 129 countries during the period 1970-2007. Our main findings are threefold. First, we find that overall government...
Persistent link: https://www.econbiz.de/10013123448
We propose a novel framework to analyse the macroeconomic impact of noncommunicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone gross...
Persistent link: https://www.econbiz.de/10012951354